Tags

Type your tag names separated by a space and hit enter

Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
Maturitas. 2008 Dec 20; 61(4):345-9.M

Abstract

OBJECTIVE

There is evidence that long-term hormone replacement therapy (HRT) is associated with an increased breast cancer risk. The aim of this study was to assess the effects of tibolone on estrogen and progesterone receptors in comparison to the effects of conventional HRT in the breast of surgically postmenopausal macaques.

METHOD

Sixty macaques were bilaterally ovariectomized 3 months before hormonal treatment was initiated. The animals were randomized into four treatment groups, including tibolone (TIB), conjugated equine estrogens (CEE), conjugated equine estrogens+medroxyprogesterone acetate (CEE+MPA) and control animals (C). After 2 years treatment, breast tissues were collected, fixed and paraffin embedded. Immunohistochemistry assays with monoclonal antibodies for estrogen receptors (ERalpha and ERbeta) and progesterone receptors (PRA and PRB) were performed.

RESULTS

The expression of ERalpha was markedly decreased in the CEE+MPA group as compared to C and TIB groups. The TIB group was not different from the C and CEE groups. No significant differences were found for ERbeta immunostaining. The expression of PRA was strongly increased in the TIB group as compared to the C and CEE+MPA groups. Immunostaining of PRB was increased in the CEE and TIB treated animals as compared to both C and CEE+MPA groups.

CONCLUSIONS

Tibolone increased the expression of both PRA and PRB, without affecting ERalpha and ERbeta expression in the macaque breast. These findings indicate that the effects of tibolone in breast tissue could be mediated via differential regulation of PRA and PRB isoforms and therefore distinct from those observed with conventional HRT.

Authors+Show Affiliations

Division for Reproductive Endocrinology, Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18980817

Citation

Ma, L, et al. "Effects of Tibolone and Conventional HRT On the Expression of Estrogen and Progesterone Receptors in the Breast." Maturitas, vol. 61, no. 4, 2008, pp. 345-9.
Ma L, Hofling M, Masironi B, et al. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast. Maturitas. 2008;61(4):345-9.
Ma, L., Hofling, M., Masironi, B., von Schoultz, B., Cline, J. M., & Sahlin, L. (2008). Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast. Maturitas, 61(4), 345-9. https://doi.org/10.1016/j.maturitas.2008.09.018
Ma L, et al. Effects of Tibolone and Conventional HRT On the Expression of Estrogen and Progesterone Receptors in the Breast. Maturitas. 2008 Dec 20;61(4):345-9. PubMed PMID: 18980817.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast. AU - Ma,L, AU - Hofling,M, AU - Masironi,B, AU - von Schoultz,B, AU - Cline,J M, AU - Sahlin,L, Y1 - 2008/11/05/ PY - 2008/07/09/received PY - 2008/09/12/revised PY - 2008/09/15/accepted PY - 2008/11/5/pubmed PY - 2009/4/16/medline PY - 2008/11/5/entrez SP - 345 EP - 9 JF - Maturitas JO - Maturitas VL - 61 IS - 4 N2 - OBJECTIVE: There is evidence that long-term hormone replacement therapy (HRT) is associated with an increased breast cancer risk. The aim of this study was to assess the effects of tibolone on estrogen and progesterone receptors in comparison to the effects of conventional HRT in the breast of surgically postmenopausal macaques. METHOD: Sixty macaques were bilaterally ovariectomized 3 months before hormonal treatment was initiated. The animals were randomized into four treatment groups, including tibolone (TIB), conjugated equine estrogens (CEE), conjugated equine estrogens+medroxyprogesterone acetate (CEE+MPA) and control animals (C). After 2 years treatment, breast tissues were collected, fixed and paraffin embedded. Immunohistochemistry assays with monoclonal antibodies for estrogen receptors (ERalpha and ERbeta) and progesterone receptors (PRA and PRB) were performed. RESULTS: The expression of ERalpha was markedly decreased in the CEE+MPA group as compared to C and TIB groups. The TIB group was not different from the C and CEE groups. No significant differences were found for ERbeta immunostaining. The expression of PRA was strongly increased in the TIB group as compared to the C and CEE+MPA groups. Immunostaining of PRB was increased in the CEE and TIB treated animals as compared to both C and CEE+MPA groups. CONCLUSIONS: Tibolone increased the expression of both PRA and PRB, without affecting ERalpha and ERbeta expression in the macaque breast. These findings indicate that the effects of tibolone in breast tissue could be mediated via differential regulation of PRA and PRB isoforms and therefore distinct from those observed with conventional HRT. SN - 0378-5122 UR - https://www.unboundmedicine.com/medline/citation/18980817/Effects_of_tibolone_and_conventional_HRT_on_the_expression_of_estrogen_and_progesterone_receptors_in_the_breast_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-5122(08)00252-1 DB - PRIME DP - Unbound Medicine ER -